Therapeutic Strategies for Heart Failure
Editat de Naoki Satoen Limba Engleză Paperback – 7 iun 2019
This book introduces pathophysiology and practical heart failure (HF) management at the acute, in-hospital stages during hospitalization and also in the end-stages of HF. Given its increasing incidence and prevalence, we live in a world that is essentially facing an HF pandemic. A country with an ageing population, Japan is unique in terms of the selection of medical treatment, diagnostic techniques, team managing and other approaches.
This book sheds new light on the clinical challenges involved in reducing re-hospitalization and improving patients’ prognosis and ADL/QOL, while also reporting on the status quo in Japan. By highlighting these challenges and the methods used to address them, it will encourage experts around the globe to intensively discuss and accelerate research in this field. Including contributions by authors who have played central roles in managing HF in Japan, the book offers an indispensable guide not only for clinicians, technicians and nurses inthis field, but also for general physicians, emergency physicians and all others who are involved in the management of acute and end-stage HF.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 426.67 lei 38-45 zile | |
Springer – 7 iun 2019 | 426.67 lei 38-45 zile | |
Hardback (1) | 440.81 lei 38-45 zile | |
Springer – 8 feb 2018 | 440.81 lei 38-45 zile |
Preț: 426.67 lei
Preț vechi: 449.13 lei
-5% Nou
Puncte Express: 640
Preț estimativ în valută:
81.67€ • 85.73$ • 67.46£
81.67€ • 85.73$ • 67.46£
Carte tipărită la comandă
Livrare economică 27 ianuarie-03 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9784431567684
ISBN-10: 4431567682
Pagini: 92
Ilustrații: IX, 92 p. 36 illus., 20 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:Softcover reprint of the original 1st ed. 2018
Editura: Springer
Colecția Springer
Locul publicării:Tokyo, Japan
ISBN-10: 4431567682
Pagini: 92
Ilustrații: IX, 92 p. 36 illus., 20 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:Softcover reprint of the original 1st ed. 2018
Editura: Springer
Colecția Springer
Locul publicării:Tokyo, Japan
Cuprins
Chapter 1. The Concept of Heart Failure - Chronic diseases accompanied by an attack of acute exacerbation.- Chapter 2. Biomarkers: new horizon for heart failure practice.- Chapter 3. Congestion: historical and pathophysiological review and the concept of fundamental management for hospitalized heart failure.- Chapter 4. Therapeutic Strategies of Refractory Heart Failure.- Chapter 5. Multidisciplinary Management of End-Stage Heart Failure.
Notă biografică
Dr. Naoki Sato, Internal Medicine and Cardiology, Nippon Medical School
Textul de pe ultima copertă
This book introduces pathophysiology and practical heart failure (HF) management at the acute, in-hospital stages during hospitalization and also in the end-stages of HF. Given its increasing incidence and prevalence, we live in a world that is essentially facing an HF pandemic. A country with an ageing population, Japan is unique in terms of the selection of medical treatment, diagnostic techniques, team managing and other approaches.This book sheds new light on the clinical challenges involved in reducing re-hospitalization and improving patients’ prognosis and ADL/QOL, while also reporting on the status quo in Japan. By highlighting these challenges and the methods used to address them, it will encourage experts around the globe to intensively discuss and accelerate research in this field. Including contributions by authors who have played central roles in managing HF in Japan, the book offers an indispensable guide not only for clinicians, technicians and nurses in this field, but also for general physicians, emergency physicians and all others who are involved in the management of acute and end-stage HF.
Caracteristici
Japan has unique characteristics valuable as a sample and challenge discussion/research on the clinics in the field Shedding light on the clinical challenges and improving the prognosis Editors have taken a central role in managing HF